Sharda Cropchem Limited — PPTs, 25-07-2025: Investor Presentation

Here is the summary:

**Financial Highlights:**

Sharda Cropchem reported a strong Q1 FY26, with total revenue up 25% to ₹985 Cr. Agrochemical segment revenue grew 25% to ₹846 Cr, and non-agrochemicals rose 31% to ₹139 Cr. Gross margins expanded significantly by 630 basis points to 35.5%. EBITDA surged 67% to ₹142 Cr, and Profit After Tax (PAT) soared 424% to ₹143 Cr. The company reduced working capital by 18 days, maintaining a strong balance sheet.

**Strategic Initiatives & Growth Drivers:**

The company operates on an asset-light business model, focusing on intellectual property and registrations. It boasts 2,981 procured registrations and 1,021 applications pending globally. Key strategies include forward integration by building a stronger sales force, expanding and strengthening distribution presence, and continued investment in product registrations for generic molecules. CAPEX incurred in Q1 FY26 was ₹114 Cr.

**Business Developments:**

Sharda Cropchem continues to expand its global footprint, now present in over 80 countries with 525 third-party distributors and a growing sales force of 500+. The company has successfully adopted a "factory-to-farmer" approach, aiming to be a one-stop solution provider.

**Market Position & Competitive Advantage:**

As an IP-driven company, Sharda Cropchem holds a strong position in the generic crop protection chemicals industry, especially in Advanced Markets like Europe, North America, and Latin America, leveraging its extensive dossier library for diversified product offerings.

**Investor Implications:**

The robust Q1 FY26 performance, marked by significant revenue and profit growth alongside margin expansion, indicates positive growth potential. The strategic focus on global market penetration, asset-light model, and continuous investment in registrations positions the company for sustained long-term growth.